MEZZION

Welcome to the Brand page for “MEZZION”, which is offered here for Pharmaceutical preparations for the treatment of diseases and disorders, pharmaceutical preparations for the treatment of cardiac diseases and disorders; pharmaceutical preparations for the treatment of cardiac diseases and disorders, single ventricle heart disease (svhd), including svhd subjects who have undergone fontan palliation; medicinal preparations for cardiac disease, single ventricle heart disease (svhd); pharmaceuticals, drugs for the treatment of cardiac disease, single ventricle heart disease (svhd), including svhd subjects who have undergone fontan palliation;medical testing and screening services, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders, single ventricle heart disease (svhd), including svhd subjects who have undergone fontan palliation;medical and pharmaceutical research for the treatment of cardiac disease and disorders, single ventricle heart disease (svhd), including svhd subjects who have undergone fontan palliation and development services; scientific and technological research services related thereto, scientific research services for the treatment of cardiac disease, single ventricle heart disease (svhd), including svhd subjects who have undergone fontan palliation ; medical testing services, providing medical testing services and information in the field of the treatment of cardiac disease, single ventricle heart disease (svhd), including svhd subjects who have undergone fontan palliation; conducting clinical trials for others;.

Its status is currently believed to be active. Its class is unavailable. “MEZZION” is believed to be currently owned by “Mezzion Pharma Co., Ltd.”